Projected Earnings Date: 2025-02-06    (Delayed quote data   2025-01-06)
Last
 45.78
Change
 ⇓ -0.76   (-1.63%)
Volume
  456,789
Open
 46.08
High
 46.71
Low
 45.73
8EMA (Daily)
 45.90
40EMA (Daily)
 44.99
50EMA (Daily)
 44.32
STO (Daily)
 27.984
MACD Hist (Daily)
 -0.431
8EMA (Weekly)
 45.037
40EMA (Weekly)
 38.40
50EMA (Weekly)
 37.58
STO (Weekly)
 60.159
MACD Hist (Weekly)
 0.597
PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com